FDA Inspection 1244028 — Corden Pharma Bergamo SPA
The FDA completed an inspection of Corden Pharma Bergamo SPA on Jun 26, 2024 in Treviglio. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 26, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Treviglio (Italy)